跳至主要内容
临床试验/NCT04820764
NCT04820764招募中不适用

Early Feasibility Study of the CardioMech Mitral Valve Repair System (MVRS)

CardioMech AS24 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2021年7月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
CardioMech AS
入组人数
25
试验地点
24
主要终点
Freedom from serious adverse events determined to be related to the CardioMech MVRS device or procedure

研究概览

简要总结

Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

详细描述

The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+), symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary heart team.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eighteen (18) years of age or greater
  • Moderate to severe (≥3+) or severe (≥4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail
  • Intermediate or high surgical risk for mitral valve repair

排除标准

  • History of rheumatic heart disease
  • History of prior endocarditis
  • History of prior repair or replacement of the mitral valve, or annuloplasty
  • Severely calcified mitral leaflet or has evidence of calcification in the grasping area of the leaflets that would prevent leaflet anchor positioning and deployment
  • Complex mechanism of MR (leaflet perforation, severe leaflet calcifications, commissural extension, commissural prolapse, multiple flail or prolapsing segments, cleft) present on required imaging

研究组 & 干预措施

CardioMech Mitral Valve Repair System (MVRS)

Experimental

干预措施: CardioMech MVRS (Device)

结局指标

主要结局

Freedom from serious adverse events determined to be related to the CardioMech MVRS device or procedure

时间窗: 30 days

Change in MR grade

时间窗: 30 days

次要结局

未报告次要终点

研究者

发起方
CardioMech AS
申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验